This trial will compare the safety and effectiveness of a new minimally-invasive surgery for kidney stones to the current standard.
1 Primary · 5 Secondary · Reporting Duration: 1 week after surgery
Active Control
140 Total Participants · 2 Treatment Groups
Primary Treatment: Inpatient PCNL with nephrostomy tube · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: